Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Active not recruiting 3Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Neoplasm Metastasis 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Genetic Profile × Clear all
NCT05385081 2022-05-23

PRECODE

Odense University Hospital

Phase NA Unknown
900 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04190667 2019-12-10

Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer

Peking Union Medical College Hospital

Unknown
1,300 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡